Medical devices labeling

Labeling medical devices in accordance with labeling regulations 21 CFR 801 or 21 CFR 809. 

Other expansions of FDA s authority include the Dmg Price Competition and Patent Term Restoration Act of 1984, commonly known as the 1984 Amendments or the Waxman-Hatch Act, which was passed to attain quicker marketing of safe, effective, and less expensive generic dmgs and the Safe Medical Device Amendments of 1990, which was passed to correct perceived weaknesses in the implementation of the 1976 Device Amendments. Congress further expanded FDA authority over nutrition labeling and health and nutrient content claims on food labels with the Nutrition Labeling and Education Act of 1990. 

The sampling kit consists of the labelled urea, which is a drug a sampling straw, which is a device and a sample container, which would be considered an in-vitro diagnostic (IVD) medical device under EU definitions. Other examples of diagnostic drug products used in conjunction with medical devices include dyes administered to visualise blocked veins and arteries. 

Table 10.3 Harmonised standards for labelling of medical devices.

There are five fundamental elements of FDA regulation of medical devices (1) facility registration and product listing (2) safe use of investigational devices (3) premarket notification (unless exempt) and product labeling ... 

Food and Drug Administration, Department of Health and Human Services Final Rule, Natural rubber-containing medical devices user labeling. Fed Reg 62 51021, 1997... 

The law abolishes the long-standing prohibition on dissemination by manufacturers of information about unapproved uses of drugs and medical devices. The act allows a firm to disseminate peer-reviewed journal articles about an ojf-label indication of its product, provided the company commits itself to file, within a specified timeframe, a supplemental application based on appropriate research to establish the safety and effectiveness of the unapproved use.3... 

Paper and board packaging is used mainly for secondary and tertiary packaging (e.g., labels, leaflets, cartons, and cases). Various dressings, pouches, and medical devices have paper as a contact material. 

But DSHEA is very different then the standard approval process for drugs and medical devices, and emphasizes the regulatory enforcement of label claims and advertising and marketing issues rather than the efficacy and quality of the supplements themselves. Unlike new drug and medical device applications, controlled clinical trials aren t part of the supplement review process, nor is any FDA inspection of a company s manufacturing facilities or quality control systems. 

The harmonization activity should further the FDA s mission to protect the public health by, among other things, ensuring that food is safe and otherwise not adulterated or misbranded that human and veterinary drugs, human biological products, and medical devices are safe and effective as required by law and are not adulterated or misbranded that cosmetics are not adulterated or misbranded that electronic product radiation is properly controlled and that all of these products are labeled truthfully and informatively. 

The FDA is an agency within the PHS, which in turn is a part of the DHHS. The FDA regulates over 1 trillion worth of products, which account for 25 cents of every dollar spent annually by American consumers. The FDA touches the lives of virtually every American, every day, for it is FDA s job to see that the food we eat is safe and wholesome, the cosmetics we use will not harm us, the medicines and medical devices we use are safe and effective, and radiation-emitting products such as microwave ovens will not cause harm. Feed and drugs for pets and farm animals also come under FDA scrutiny. The FDA also ensures that all of these products are labeled truthfully with the information people need to use them properly. 

Medical Device Measurement Systems Statistical Analysis Systems Labeling System Electronic Document Management Systems... 

Regulatory authorities have also stated that labeling is not limited to the immediate product container or package insert, but also includes all promotional material that is distributed and/or published in connection with a particular product or medical device. 

The FDA has jurisdiction over prescription drug advertising and promotion, while the FTC has jurisdiction over the advertising and promotion of over-the-counter (OTC) medicines, as well as dietary supplements and medical devices (other than restricted devices as defined in the FD C Act). The FDA retains full jurisdiction over the labeling of all medical products, including OTC drugs and dietary supplements. 

CFR part 801 natural rubber-containing medical devices, user labeling. Fed. Reg. 1997, 62 (189), 51021-51030. 

---